Super-enhancers in hepatocellular carcinoma: regulatory mechanism and therapeutic targets
Abstract Super-enhancers (SEs) represent a distinct category of cis-regulatory elements notable for their robust transcriptional activation capabilities. In tumor cells, SEs intricately regulate the expression of oncogenes and pivotal cancer-associated signaling pathways, offering significant potent...
Saved in:
Main Authors: | Xuejin Lu, Meizi Zhu, Xingyue Pei, Jinhu Ma, Rui Wang, Yi Wang, Shuwen Chen, Yan Yan, Yaling Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-024-03599-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PNMA1 is a novel immune modulator and therapeutic target in hepatocellular carcinoma linked to bile acid metabolism
by: Hongyu Chu, et al.
Published: (2025-01-01) -
Recent updates of centromere proteins in hepatocellular carcinoma: a review
by: Zhongyuan Yang, et al.
Published: (2025-02-01) -
The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights
by: Valentina Arrè, et al.
Published: (2025-01-01) -
New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy
by: Mengran Li, et al.
Published: (2025-01-01) -
Super-enhancers in tumors: unraveling recent advances in their role in Oncogenesis and the emergence of targeted therapies
by: Yumeng Ji, et al.
Published: (2025-01-01)